Model could improve design of vaccines, immunotherapies

The body's immune system defeats diseases by sensing foreign invaders, such as bacteria or viruses, then mounting a response against them.

A new model could improve the design of vaccines and immunotherapies. Photo: NIH/NCI

But how immune cell receptors work together to sense multiple molecules and make these decisions remained a mystery. Now, researchers at the Pritzker School of Molecular Engineering at the University of Chicago have discovered a general property for understanding how these cells sense and respond to microbial signals.

By studying how foreign molecules impact immune cells, they found that while the effect of a single molecule does not predict the effect of two molecules together, the complexity stops there.

In fact, the effect of singles and pairs of molecules can be used to predict how triplets of molecules work.

The study, led by Nicolas Chevrier, led to a more effective cancer immunotherapy in mice and could lead to more effective vaccines for both existing and novel viruses.

Each of the body's innate immune cells has receptors that recognize molecules from foreign pathogens. To fight off bacteria or viruses, those cells make decisions in response to complex combinations of inputs from those molecules.

Though researchers have studied singular pathways, how these pathways work together is still not well understood.

Chevrier and his collaborators set out to better understand how cells integrate multiple signals into a response. Not only would that answer a basic question of biology, it would help design vaccines that use adjuvants, molecules that modulate the immune system and enhance its response.

Though just a few vaccines currently use them, adjuvants may be the key to developing new kinds of vaccines. If researchers could find the right combination to target more adjuvants, vaccines could become more effective. (National Science Foundation)

YOU MAY ALSO LIKE

Researchers show how to target a 'shape-shifting' protein in Alzheimer’s disease

A new study suggests that it is possible to design drugs that can target a type of shape-shifting protein involved in Alzheimer’s disease, which was previously thought to be undruggable.

New technology tracks role of macrophages in cancer spread

Macrophages, cells that help engulf and destroy harmful organisms in the body, tend to be characterized as the Jekyll and Hydes of the immune system.

Tiny golden bullets could help tackle asbestos-related cancers

Gold nanotubes could be used to treat mesothelioma, a type of cancer caused by exposure to asbestos, according to a team of researchers at the Universities of Cambridge and Leeds.

Why it takes guts to protect the brain against infection

The brain is uniquely protected against invading bacteria and viruses, but its defence mechanism has long remained a mystery. Now, a study in mice, confirmed in human samples, has shown that the brain has a surprising ally in its protection: the gut.

Drug-resistant hospital bacteria persist even after deep cleaning, genomic study reveals

Scientists have used genome sequencing to reveal the extent to which a drug-resistant gastrointestinal bacterium can spread within a hospital, highlighting the challenge hospitals face in controlling infections.

Marmoset study finds single brain region linking depression and anxiety, heart disease, and people’s sensitivity to treatment

Over-activity in a single brain region called the subgenual anterior cingulate cortex (sgACC) underlies several key symptoms of mood and anxiety disorders, but an antidepressant only successfully treats some of the symptoms.